Searchable abstracts of presentations at key conferences in endocrinology

ea0084ps2-07-59 | Graves’ Disease 1 | ETA2022

TPO antibody status prior to first radioactive iodine therapy as a predictive parameter for early hypothyroidism in graves’ disease

Verdickt Sebastien , Van Nes Falco , Moyson Carolien , Maes Toon , Van Crombrugge Paul , Van den Bruel Annick , Decallonne Brigitte

Introduction: Several studies identified pre-treatment parameters that could help in the prediction of the thyroid functional outcome after radioactive iodine therapy (RAI) in Graves’ disease. However, the role of the thyroid peroxidase antibody (TPO Ab) status is not well studied.Objectives: We investigated if a positive TPO Ab status before radioactive iodine (RAI) therapy in patients with Graves’ hyperthyroidism is a predictive factor for de...

ea0088013 | Abstracts | BES2022

TPO antibody status prior to first radioactive iodine therapy as a predictive parameter for hypothyroidism in Graves’ disease

Sebastien Verdickt , Nes Falco Van , Carolien Moyson , Toon Maes , Crombrugge Paul Van , den Bruel Annick Van , Brigitte Decallonne

Objective: We investigated if a positive thyroid peroxidase antibody (TPO Ab) status before radioactive iodine (RAI) therapy in patients with Graves’ hyperthyroidism is a predictive factor for developing hypothyroidism after RAI.Methods: We performed a retrospective study of patients with Graves’ hyperthyroidism with known TPO Ab status, receiving a first administration of RAI. Patients from 4 thyroid outpatient centres in Belgium receiving a f...